Topic: familial hyperch
Raised blood cholesterol is a major risk factor in developing coronary heart disease and other cardiovascular diseases. Effective and well-tolerated lipid-lowering treatment improves outcomes for patients with elevated cholesterol, especially those with familial hypercholesterolaemia.
The updated NICE clinical guideline (CG71) on the identification and management of familial hypercholesterolaemia (FH) recommends that those at risk of FH should be offered DNA tests to confirm they have the condition. Previously, LDL-C levels have been used but they are not always accurate.